COVIGRO: Impact of COVID-19 and the vaccine against SARS-CoV-2 on the development of the placenta and the fetus

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:239 publications

Grant number: Unknown

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2021
  • Known Financial Commitments (USD)

    $211,866.94
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    N/A

  • Research Location

    Canada
  • Lead Research Institution

    Université Laval
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)Children (1 year to 12 years)Infants (1 month to 1 year)Newborns (birth to 1 month)

  • Vulnerable Population

    Pregnant women

  • Occupations of Interest

    Unspecified

Abstract

Google translate: Scientific data regarding the impact of COVID-19 on pregnancy is limited but suggests an increase in complications such as premature birth and preeclampsia. At the same time, scientific data are limited regarding the effectiveness of the COVID-19 vaccine given during pregnancy and whether gestational age can influence its effectiveness and/or impact on the outcome of the pregnancy. We will compare two cohorts of pregnant women, one recruited before the pandemic (2017-2018) and one recruited during the 2020-2021 pandemic. Using blood samples collected at different times of pregnancy, and using a questionnaire, we will be able to establish if the patient has been infected with COVID-19 and if she has received the vaccine. We will assess the effect of COVID-19 on placental development and fetal development, as well as the rate of complications. We will finally assess whether the vaccine received during pregnancy is as effective as the vaccine received before or after pregnancy.]

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Development and Validation of the Intimate Partner Violence Workplace Disruptions Assessment (IPV-WDA).

Elucidating directed neural dynamics of scene construction across memory and imagination

Implementing a Novel Resident-Led Peer Support Program for Emergency Medicine Resident Physicians.

Cross-Activity Analysis of CRISPR/Cas9 Editing in Gene Families of <i>Solanum lycopersicum</i> Detected by Long-Read Sequencing.

Creating health systems citizens: enhanced professional identity formation through a para-curricular distinction track in health systems transformation and leadership.

A Comparison of Clinical Diagnostic Classification Criteria Used in Longitudinal Cohort Studies of the Alzheimer's Disease Continuum: A Systematic Review.

Identification and Characterization of a Rare Exon 22 Duplication in <i>CFTR</i> in Two Families.

Structural Rearrangement in Cyclic Cu(II) Pyridyltriazole Complexes: Oxidation of Dabco to Oxalate and CO<sub>2</sub> Conversion to Carbonate.

Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use.